Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.

Strategic Areas

Menarini Benelux N.V./S.A. also owes its dynamic growth to the innovative quality of its medicines targeting strategic areas: 


  • Cardiology: our medicines are used to treat patients with hypertension and cardiac insufficiency. With an innovative mechanism of action, they have also been the subject of consistent research in the most prestigious universities. Used in combination with a diuretic, they are capable of meeting the most acute needs. 
  • Diabetology: In this field, we have two drugs to treat patients with type II diabetes. Through its Diagnostics Division, Menarini also provides hospitals, doctors and their patients with glycaemia measuring and self-monitoring devices. . Allergology, we have a non-sedating H1-antihistamine drug, approved for the symptomatic treatment of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria that allows, both in acute and chronic conditions, to relieve patient complaints aiming to improve the quality of live of the patients. 
  • Gastroenterology: treating both acute and recurring problems is essential. One of our drugs, recognized for its quality in international meta-analyses, is used to treat IBS (Irritable Bowel Syndrome), a condition of which one in five Belgians suffers. 
  • Traumatology / rheumatology
    - A well-known topical anti-inflammatory product, also recognized for its quality in meta-analyses, helps patients suffering from minor and major problems related to the musculoskeletal system.  
    - Patients with gout are also concerned, since Menarini has put on the market in 2012 an innovative treatment for adults suffering from chronic hyperuricaemia, in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis). There had been no new molecule since 1975.
  • Pediatry: A range of infant milk formulas is also available to the medical profession and parents. The composition of these formulas is adapted to the needs and development of the nursing infant. The company offers 11 many different formulas which include infant formulas adapted to different ages and therapeutic formulas to provide assistance in difficult situations. 
  • Urology: we have two medications. The first one is for the treatment of erectile dysfunction. The second is the only drug approved to help patients with premature ejaculation.

    Please be informed that the links above will take you to a website the content of which has been designed in accordance with country specific laws and regulations.

 

OUR VALUES

10 core values which originated our group's success. READ MORE »

DIVISION DIAGNOSTICS

Advanced technology. READ MORE »

QUALITY FIRST

Quality: starting point and endpoint criteria for our medicines. READ MORE »

MENARINI IN THE WORLD

The Menarini Group has companies located almost all over the world. READ MORE »
Scroll Top